所有这些都需要一个在临床、科研和管理方面的新方法,来关注佐剂的短期和长期安全性问题。
All this requires a new clinical, scientific and regulatory approach, with attention to the short - and long-term safety of adjuvants.
对于药物,科研的黄金标准是随机临床实验,即一部分患者用药而另一部分用安慰剂。
With drugs, the gold standard for research is a randomized clinical trial in which some patients take a drug and others a placebo.
我们的科研成果特别需要在临床实验上取得成功.
应用推荐